DM - To regulate blood sugar levels in diabetics and improve the condition of liver diseases

EFILA increases the amount of EPS Beta-Glucan which has been proven to improve insulin responses and thus helps with regulating blood sugar levels in diabetics. It encourages glucose metabolism while improving gut health.

A study has also shown that Beta Glucan can reduce liver damage by reducing liver inflammation and controls fatty liver.

Buy Now

EFILA Wine Fairy Hangover Relief

EFILA Wine Fairy Hangover Relief protects your liver, stomach and gut as you drink by increasing EPS Beta-Glucans in your body.

This product contains fructose which helps with the breaking down of alcohol and aids in the removal of alcohol in your bloodstream.

Taking it before your drinks prevents heartburns due to alcohol and significantly reduces the level of intoxication.

Taking it after your drink will reduce hangover symptoms and help with faster recovery the next day.

Buy now

Longrunn Medical Technologies

About us

ABOUT LONGRUNN
Longrunn Medical Technologies was established in Singapore. We are committed to restoring pancreatic and liver function to prevent and treat diabetes and liver disease. Our team has more than 15 years of research experience and aims to develop natural, safe and effective products for diabetic patients

Our technology

After 20 years of research, our scientists were the first to cultivate the patented micro-organism strain Irpex lacteus fk. The identified strain was isolated and deposited with the international patent microorganism depository institution: the Microbial Bank of the National Agricultural Science Institute in Korea in 2021.

In early 2022, we obtained a patent for the invention and utilization of metabolite EFILA derived from this strain for the prevention and treatment of disease.

EFILA is a patented strain cultivated from medicinal mushroom strains found on pine trees and is 100% natural.

Through clinical studies, EFILA has been proven to have significant positive impacts on the prevention and treatment of diabetes and liver diseases. Users have also reported positive effects on the eyes, skin, and sleep. Efila can prevent aging in all aspects of the human body.

Our team of scientists in Korea has stabilized the strain cultivation process, and the active substance yield has increased from the 20% initially to 100% today. We have also developed a factory manufacturing process that has reached a stable level for large-scale production. We will continue to research upon the preventive and therapeutic effects of Irpex lacteus fk and EFILA on liver diseases,
as well as explore its potential in anti-aging research.